Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model

Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model

Background: Cardiac magnetic resonance (CMR) quantitative T1 and T2 mapping offers a non-invasive means to evaluate early cardiotoxicity changes. This study aimed to pinpoint the earliest CMR indicators of myocardial injury in Anthracycline-induced cardiotoxicity (AIC) and to elucidate the connectio...

Full description

Bibliographic Details
Main Authors:	Yurou Hu, Peisong Ma, Lin Chen, Juan Liu, Yongning Shang, Wang Jian
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Heliyon
Subjects:	T1 and T2 mapping CMR Anthracycline-induced cardiotoxicity Animal models
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023090539

Similar Items

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Genetics of Anthracycline-Associated Cardiotoxicity
by: Talal Khalid Al-Otaibi, et al.
Published: (2022-04-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know
by: Armando Ferrera, et al.
Published: (2023-05-01)

A journey in anthracycline-induced cardiotoxicity with emphasizing on doxorubicin: a review article
by: Atlasi Safaei, et al.
Published: (2021-11-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
by: Yun Qiu, et al.
Published: (2023-12-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
by: Leila Mabudian, et al.
Published: (2022-09-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
by: Ian Osoro, et al.
Published: (2022-12-01)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
by: Maryam Moossavi, et al.
Published: (2023-03-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Assessing cardiotoxicity in randomised trials of anthracycline chemotherapy
by: Kerr, A
Published: (2016)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
by: Aleksandra M. Sobiborowicz-Sadowska, et al.
Published: (2023-01-01)

MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
by: Roberto Rosenfeld, et al.
Published: (2022-06-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
by: Nhan Nguyen, et al.
Published: (2021-06-01)

Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
by: Hao Jin, et al.
Published: (2023-01-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022-12-01)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
by: Attila Feher, et al.
Published: (2022-04-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review
by: Laura J. Philip, et al.
Published: (2022-12-01)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
by: Takafumi Nakayama, et al.
Published: (2020-11-01)

Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
by: Xi Zhou, et al.
Published: (2023-10-01)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
by: Alexandros Briasoulis, et al.
Published: (2022-02-01)

Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy
by: Kasey J. Leger, et al.
Published: (2017-04-01)

Value of Left Ventricular Global Longitudinal Strain Assessed by Two-Dimensional Strain Imaging in Early Detection of Anthracycline Mediated Cardiotoxicity
by: Yasser Abdel-Hady, et al.
Published: (2022-04-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity
by: René R. Sevag Packard, et al.
Published: (2023-01-01)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines
by: Aditi A. Bhagat, et al.
Published: (2023-12-01)

Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?
by: Kader Muneer, et al.
Published: (2022-10-01)

The effect of anthracyclines in minimal doses on cardiac function of children under chemotherapy
by: Shiva Rahimi Dehgolan, et al.
Published: (2014-07-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
by: Hamid Amoozgar, et al.
Published: (2012-03-01)

Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience
by: Maria Sjöborg Alpman, et al.
Published: (2023-09-01)

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging
by: Jeremy Jong, et al.
Published: (2022-08-01)